Skip to content

Earnings yield at other companies

ALN
Alnylam PharmaceuticalsALNY
1.1%+0.8pp
Septerna, Inc. logo
Septerna, Inc.SEPN
-3.3%-1.6pp
Regenxbio logo
RegenxbioRGNX
-67.1%+73.5pp
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
1%+0.5pp
Opko Health logo
Opko HealthOPK
-24.6%-29.5pp
Ginkgo Bioworks logo
Ginkgo BioworksDNA
-80.2%-24.4pp

Other financials

Income statement

See full
Operating income-$27.3M-49.2%
Net income-$25.2M-58.7%
EPS (diluted)-$1.34-44.1%

Balance sheet

See full
Cash & equivalents$236.9M-22.8%
Total debt$4.9M+86.1%
Total equity$230.4M-23.5%
Total assets$246.6M-21.7%

Cash flow

See full
Operating cash flow-$18.4M-40.7%
CapEx$19.0K-29.6%
Free cash flow-$18.4M-40.6%

Valuation

See full
Market cap$585.51M+58.3%
Enterprise value$353.51M+438%

Returns & leverage

See full
Return on equity-31.4%
Debt / equity0.0×
Current ratio18.5×-4.4×

Where this comes from

Calculated from Tectonic Therapeutics’s reported figures.

Based on trailing twelve months.

The official record: Tectonic Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tectonic Therapeutics's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tectonic Therapeutics's earnings yield?
Tectonic Therapeutics (TECX) reported earnings yield of -14.4% in Q1 2026.
How has Tectonic Therapeutics's earnings yield changed year-over-year?
Tectonic Therapeutics's earnings yield increased by 19.0% year-over-year, from -17.8% to -14.4%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.